Breast Screening Outcomes in Women with and without a Family History of Breast and/or Ovarian Cancer

Fletcher SW Black W Harris R Report of the International Workshop on Screening for breast cancer. J Natl Cancer Inst, 1993;85:1644–56.

Kerlikowske K Grady D Rubin SM Efficacy of screening mammography. A meta-analysis. JAMA, 1995;273:149–54.

Humphrey LL Helfand M Chan BKS Breast cancer screening: A summary of the evidence for the US Preventive Services Task Force. Ann Intern Med, 2002;137:347–60.

Lipskie TL. A summary of cancer screening guidelines. Chronic Dis Can 1998; 19:112–30.

Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet, 2001;358:1389–99.

Chart PL Franssen E . Management of women at increased risk for breast cancer: Preliminary results from a new program. Can Med Assoc J, 1997;157:1235–42.

Ministry of Health and Long-Term Care (MOHLTC) Implementation Working Group for Predictive Cancer Genetics Services. Clinical risk management approaches for families at risk of inherited breast/ovarian/colorectal cancers., Toronto: MOHLTC, 2001.

Shapiro S Venet W Strax P Ten to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst, 1982;69:349–55.

Tabar L Fagerberg CJ Gad A Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group or the Swedish National Board of Health and Welfare, lancet 1985;i:829–32.

Shapiro S Coleman EA Broeders M. Breast cancer screening programmes in 22 countries: Current policies, administration and guidelines. Int J Epidemiol, 1998;27:735–42.

Day NE Williams DR Khaw KT. Breast cancer screening programmes: The development of a monitoring and evaluation system. Br J Cancer, 1989;59:954–8.

Kerlikowske K Grady D Barclay J . Positive predictive value of screening mammography by age and family history of breast cancer. JAMA, 1993;270:2444–50.

Kerlikowske K Carney PA Geller B Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med, 2000;133:855–63.

Kerlikowske K Grady D Barclay J Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA, 1996;276:33–8.

Kollias J Sibbering DM Blamey RW Screening women aged less than 50 years with a family history of breast cancer. Eur J Cancer, 1998;34:878–83.

Lalloo F Boggis CR Evans DG Screening by mammography, women with a family history of breast cancer. Eur J Cancer, 1998;34:937–40.

Moller P Maehle L Heimdal K . Prospective findings in breast cancer kindreds: Annual incidence rates according to age, stage at diagnosis, mean sojourn time, and incidence rates for contralateral cancer. The Breast, 1998;7:55–9.

Moller P Reis MM Evans G Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group. Disease Markers, 1999;15:179–86.

Macmillan RD. Screening women with a family history of breast cancer — results from the British Familial Breast Cancer Group. Eur J Surg Oncol, 2000;26:149–52.

Tilanus-Linthorst MM Bartels CC Obdeijn AL Earlier detection of breast cancer by surveillance of women at familial risk. Eur J Cancer 2000; 36:514–9.

Libstug AR Moravan V Aitken SE. Results from the Ontario Breast Screening Program, 1990–1995. J Med Screen, 1998;5:73–80.

Kleinbaum DG. Logistic regression. A self-learning text., New York: Springer-Verlag, 1994.

Statistical Analysis System (SAS). SAS User's Guide, Basics. 5th edn. Cary, NC: SAS Institute, 1990.

Sellers TA Mink PJ Cerhan JR The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer. Ann Intern Med, 1997;127:973–80.

Banks E . Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: A review. J Med Screen, 2001;8:29–34.

Kavanagh AM Mitchell H Giles GG. Hormone replacement therapy and accuracy of mammographic screening. Lancet, 2000;355:270–4.

Carney PA Miglioretti DL Yankaskas BC Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med, 2003;138:168–75.

Ziv E Shepherd J Smith-Bindman R Mammographic breast density and family history of breast cancer. J Natl Cancer Inst, 2003;95:556–8.

Elmore JG Wells CK Howard DH The impact of clinical history on mammographic interpretations. JAMA, 1997;277:49–52.

Theis B Boyd N Lockwood G Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev, 1994;3:321–7.

Parent ME Ghadirian P Lacroix A Accuracy of reports of familial breast cancer in a case-control series. Epidemiology, 1995;6:184–6.

Eerola H Blomqvist C Pukkala E Familial breast cancer in southern Finland: How prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 2000;36:1143–8.

Oza AM Boyd NF. Mammographic parenchymal patterns: A marker of breast cancer risk. Epidemiol Rev, 1993;15:196–208.

Kelsey JL Bernstein L . Epidemiology and prevention of breast cancer. Ann Rev Public Health 1996; 17:47–67.